Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
NASDAQ · Healthcare
Amylyx Pharmaceuticals, Inc. Common Stock Gross Profit 2021–2025
Amylyx Pharmaceuticals, Inc. Common Stock annual/quarterly gross profit history and growth rate from 2022 to 2025. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Amylyx Pharmaceuticals, Inc. Common Stock gross profit for the quarter ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- Amylyx Pharmaceuticals, Inc. Common Stock gross profit for the twelve months ending September 30, 2025 was 416000, a 99.85% decrease year-over-year.
- Amylyx Pharmaceuticals, Inc. Common Stock annual gross profit for 2025 was 0, a 100.00% decrease from 2024.
- Amylyx Pharmaceuticals, Inc. Common Stock annual gross profit for 2024 was 81.4 M, a 77.09% decrease from 2023.
- Amylyx Pharmaceuticals, Inc. Common Stock annual gross profit for 2023 was 355.3 M, a 1747.20% increase from 2022.
- Amylyx Pharmaceuticals, Inc. Common Stock annual gross profit for 2022 was 19.2 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amylyx Pharmaceuticals, Inc. Common Stock Gross Profit — FAQ
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) gross profit over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMLX's gross profit history?
The chart and table above show Amylyx Pharmaceuticals, Inc. Common Stock's gross profit by year and by quarter, including the growth rate.